Please login to the form below

Not currently logged in
Email:
Password:

SNG001

This page shows the latest SNG001 news and features for those working in and with pharma, biotech and healthcare.

Positive COPD data for Synairgen's SNG001 supports COVID-19 programme

Positive COPD data for Synairgen's SNG001 supports COVID-19 programme

Interim analysis from the phase 2 trial in COPD patients with confirmed respiratory viral infection found that treatment with SNG001 improved lung antiviral responses compared to placebo. ... In exacerbating patients who already required treatment with

Latest news

  • UK biotech Synairgen reveals promising early results for COVID-19 drug UK biotech Synairgen reveals promising early results for COVID-19 drug

    The double-blind, placebo-controlled phase 1 trial of SNG001 recruited 101 hospitalised COVID-19 patients from nine hospital sites across the UK. ... While three patients died after being randomised to receive the placebo, no deaths were observed among

  • UK biotech Synairgen to begin COVID-19 trial of lead candidate UK biotech Synairgen to begin COVID-19 trial of lead candidate

    SNG001 (inhaled formulation of interferon-beta-1a), as concerns grow in the UK that COVID-19 cases could soar in the comings weeks. ... SNG001 delivers a formulation of INF-beta-1a to the lungs directly via nebulisation, and is suitable for inhaled

  • AZ licenses asthma infection drug from Synairgen AZ licenses asthma infection drug from Synairgen

    The novel formulation - called SNG001 - is designed to prevent the sometimes severe exacerbations suffered by asthma patients when they develop respiratory viral infections such as colds. ... The big pharma company will also meet all future development

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Pharma deals during June 2014 Pharma deals during June 2014

    Clearly not deterred by this, AZ has moved on to build on its respiratory franchise by in-licensing Synairgen's inhaled beta interferon SNG001.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics